|
Subject: exhibited a bi-phasic pharmacokinetic profile pharm. The rat PK study, FIT1-Ig serum concentrations were very similar when determined by the two different ELISA methods, indicating that the molecule was intact, and capable of binding both antigens in vivo. Upon IV dosing, FIT1-Ig "exhibited a bi-phasic pharmacokinetic profile", consisting of a distribution phase followed by an elimination phase, similar to the PK profile of conventional IgG molecules.как нормально пеевести "exhibited a bi-phasic pharmacokinetic profile" Заранее большое спасибо! |
|
link 7.06.2016 4:55 |
| При внутривенном введении для Fit1-ig характерен двухфазный фармакокинетический профиль |
| You need to be logged in to post in the forum |